TriLink supplies reagents for SOLiD system:
This article was originally published in Clinica
San Diego, California-based reagents manufacturer TriLink Biotechnologies will supply Applied Biosystems with chemically synthesised nucleotides for the latter's SOLiD genetic analysis platform. TriLink will provide Applied (Foster City, California) with custom dye-labelled nucleotides, which will be used by the SOLiD system as part of its DNA sequencing process. Financial terms of the deal were not discussed.
You may also be interested in...
Europe's largest online pharmacy is calling for online sales of OTC medicines to be allowed in its home market Switzerland, to increase the supply of crucial products to help people manage the symptoms of COVID-19, such as headaches, fever, diarrhoea, coughs, colds or nausea.
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Novartis's Jakavi joins the likes of Roche's Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients.